Gamifant

San Diego
Pharma

Sobi rolls more data backing new rare disease drug Gamifant

Last month, Sobi snagged an FDA approval for rare disease drug Gamifant. And Monday, it unveiled more of the data that secured the agency’s favor.
Carly Helfand Dec 3, 2018 7:30pm